Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 2, 2026

U.S. District Court Issues Decision Regarding CINVANTI® Patents
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
Realize Medical Appoints Canadian Technology Leader Andrew Waitman to Board of Directors
AKK PROBIO Becomes the First Gut-Derived Akkermansia muciniphila to Complete FDA NDI Notification
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
ProKidney Appoints Kenneth Locke as Chief Technical Officer
Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution
Exclusive distribution agreement marks Nanox’s entry into the Peruvian market
Cingulate Receives Complete Response Letter from FDA for CTx-1301
Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

Share this page:

Sign up for:

Health Press Barbados

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.